Literature DB >> 22994380

Diagnostic accuracy of liquid-based endometrial cytology in the evaluation of endometrial pathology in postmenopausal women.

C Remondi1, F Sesti, E Bonanno, A Pietropolli, E Piccione.   

Abstract

OBJECTIVE: The aim of this study was to compare liquid-based endometrial cytology with hysteroscopy and endometrial biopsy regarding its diagnostic accuracy in a series of postmenopausal women with abnormal uterine bleeding (AUB) or asymptomatic women with thickened endometrium assessed by transvaginal ultrasound as a screening procedure.
METHODS: Inclusion criteria were: menopausal status; the presence of AUB and/or thickened endometrium assessed by ultrasound (cut-off 4 mm); a normal Papanicolaou (Pap) smear; and no adnexal pathology at ultrasound. Exclusion criteria were: previous endometrial pathology; and previous operative hysteroscopy. Of 768 postmenopausal women referred to our general gynaecology clinics, 121 fulfilled the inclusion criteria and were recruited to the trial. Twenty-one refused to participate. Cytological sampling was carried out by brushing the uterine cavity using the Endoflower device with no cervical dilation and the vial was processed using a ThinPrep® 2000 automated slide processor. The slides were stained using a Pap method.
RESULTS: In 98 cases with histological biopsies, endometrial cytology detected five cases of endometrial carcinoma, 10 of atypical hyperplasia and 47 of non-atypical hyperplasia; 36 cases were negative. In two cases cytology was inadequate because of uterine cervical stenosis. Taking atypical hyperplasia or worse as a positive test and outcome, the diagnostic accuracy of the endometrial cytology was 93.5%, with a sensitivity of 92% and specificity of 95%, a positive predictive value of 73% and a negative predictive value of 99%. All the carcinomas were detected by cytology. Only 42% of women with a positive diagnosis were symptomatic. The cytological sampling was well tolerated by all patients. No complication was registered.
CONCLUSIONS: Liquid-based endometrial cytology can be considered an useful diagnostic method in the detection of endometrial pathology as a first-line approach, particularly if associated with transvaginal ultrasound.
© 2012 John Wiley & Sons Ltd.

Entities:  

Keywords:  endometrial carcinoma; endometrial cytology; endometrial hyperplasia; histology; liquid-based endometrial cytology; transvaginal ultrasound

Mesh:

Year:  2012        PMID: 22994380     DOI: 10.1111/cyt.12013

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  6 in total

1.  Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013-12-30

2.  Combining endometrium sampling device and SurePath preparation to screen for endometrial carcinoma: a validation study.

Authors:  Jia Wen; Rui Chen; Jian Zhao; Yin Dong; Xi Yang; Qin-Ping Liao
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

3.  Role of Liquid-based Cytology and Cell Block in the Diagnosis of Endometrial Lesions.

Authors:  Hui Zhang; Jia Wen; Pi-Li Xu; Rui Chen; Xi Yang; Lian-Er Zhou; Ping Jiang; An-Xia Wan; Qin-Ping Liao
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

4.  Endometrial Cytology as a Method to Improve the Accuracy of Diagnosis of Endometrial Cancer: Case Report and Meta-Analysis.

Authors:  Qing Wang; Qi Wang; Lanbo Zhao; Lu Han; Chao Sun; Sijia Ma; Huilian Hou; Qing Song; Qiling Li
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

5.  Evaluation of menopausal endometrial lesions via mathematical modeling clinical indicators and ultrasonographic parameters.

Authors:  Yamei Zhu; Lei Tang; Qiao Chen; Man Chen
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

6.  Clinically Applicable Pathological Diagnosis System for Cell Clumps in Endometrial Cancer Screening via Deep Convolutional Neural Networks.

Authors:  Qing Li; Ruijie Wang; Zhonglin Xie; Lanbo Zhao; Yiran Wang; Chao Sun; Lu Han; Yu Liu; Huilian Hou; Chen Liu; Guanjun Zhang; Guizhi Shi; Dexing Zhong; Qiling Li
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.